479 related articles for article (PubMed ID: 25409123)
1. Accounting for neutron exposure in the Japanese atomic bomb survivors.
Cullings HM; Pierce DA; Kellerer AM
Radiat Res; 2014 Dec; 182(6):587-98. PubMed ID: 25409123
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Relative Biological Effectiveness of Neutrons across Organs of Varying Depth among the Atomic Bomb Survivors.
Cordova KA; Cullings HM
Radiat Res; 2019 Aug; 192(4):380-387. PubMed ID: 31390313
[TBL] [Abstract][Full Text] [Related]
3. Indications of the neutron effect contribution in the solid cancer data of the A-bomb survivors.
Kellerer AM; Rühm W; Walsh L
Health Phys; 2006 Jun; 90(6):554-64. PubMed ID: 16691103
[TBL] [Abstract][Full Text] [Related]
4. Neutron relative biological effectiveness for solid cancer incidence in the Japanese A-bomb survivors: an analysis considering the degree of independent effects from γ-ray and neutron absorbed doses with hierarchical partitioning.
Walsh L
Radiat Environ Biophys; 2013 Mar; 52(1):29-36. PubMed ID: 23161400
[TBL] [Abstract][Full Text] [Related]
5. Assessing the impact of neutron relative biological effectiveness on all solid cancer mortality risks in the Japanese atomic bomb survivors.
Hafner L; Walsh L; Rühm W
Int J Radiat Biol; 2024; 100(1):61-71. PubMed ID: 37772764
[TBL] [Abstract][Full Text] [Related]
6. Neutron relative biological effectiveness in Hiroshima and Nagasaki atomic bomb survivors: a critical review.
Sasaki MS; Endo S; Hoshi M; Nomura T
J Radiat Res; 2016 Nov; 57(6):583-595. PubMed ID: 27614201
[TBL] [Abstract][Full Text] [Related]
7. The impact of possible modifications to the DS86 dosimetry on neutron risk and relative biological effectiveness.
Hunter N; Charles MW
J Radiol Prot; 2002 Dec; 22(4):357-70. PubMed ID: 12546224
[TBL] [Abstract][Full Text] [Related]
8. Neutron versus gamma-ray risk estimates. Inferences from the cancer incidence and mortality data in Hiroshima.
Kellerer AM; Nekolla E
Radiat Environ Biophys; 1997 Jun; 36(2):73-83. PubMed ID: 9271794
[TBL] [Abstract][Full Text] [Related]
9. Assessing the impact of different neutron RBEs on the all solid cancer radiation risks obtained from the Japanese A-bomb survivors data.
Hafner L; Walsh L; Rühm W
Int J Radiat Biol; 2023; 99(4):629-643. PubMed ID: 36154910
[TBL] [Abstract][Full Text] [Related]
10. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
[TBL] [Abstract][Full Text] [Related]
11. Lung cancer risk in mice: analysis of fractionation effects and neutron RBE with a biologically motivated model.
Heidenreich WF; Carnes BA; Paretzke HG
Radiat Res; 2006 Nov; 166(5):794-801. PubMed ID: 17067205
[TBL] [Abstract][Full Text] [Related]
12. Effective dose of A-bomb radiation in Hiroshima and Nagasaki as assessed by chromosomal effectiveness of spectrum energy photons and neutrons.
Sasaki MS; Endo S; Ejima Y; Saito I; Okamura K; Oka Y; Hoshi M
Radiat Environ Biophys; 2006 Jul; 45(2):79-91. PubMed ID: 16807767
[TBL] [Abstract][Full Text] [Related]
13. The effect of changes in dosimetry on cancer mortality risk estimates in the atomic bomb survivors.
Preston DL; Pierce DA
Radiat Res; 1988 Jun; 114(3):437-66. PubMed ID: 3375435
[TBL] [Abstract][Full Text] [Related]
14. Stable chromosome aberrations among A-bomb survivors: an update.
Stram DO; Sposto R; Preston D; Abrahamson S; Honda T; Awa AA
Radiat Res; 1993 Oct; 136(1):29-36. PubMed ID: 8210335
[TBL] [Abstract][Full Text] [Related]
15. Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb.
Brenner DJ
Radiat Res; 1996 Apr; 145(4):501-7. PubMed ID: 8600511
[TBL] [Abstract][Full Text] [Related]
16. Experimental derivation of relative biological effectiveness of A-bomb neutrons in Hiroshima and Nagasaki and implications for risk assessment.
Sasaki MS; Nomura T; Ejima Y; Utsumi H; Endo S; Saito I; Itoh T; Hoshi M
Radiat Res; 2008 Jul; 170(1):101-17. PubMed ID: 18582156
[TBL] [Abstract][Full Text] [Related]
17. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.
Rühm W; Walsh L
Radiat Prot Dosimetry; 2007; 126(1-4):423-31. PubMed ID: 17533156
[TBL] [Abstract][Full Text] [Related]
18. Risk coefficient for gamma-rays with regard to solid cancer.
Kellerer AM; Walsh L; Nekolla EA
Radiat Environ Biophys; 2002 Jun; 41(2):113-23. PubMed ID: 12201054
[TBL] [Abstract][Full Text] [Related]
19. Impact on the Japanese atomic bomb survivors of radiation received from the bombs.
Cullings HM
Health Phys; 2014 Feb; 106(2):281-93. PubMed ID: 24378504
[TBL] [Abstract][Full Text] [Related]
20. The RBE for mouse skin irradiated with 3-MeV neutrons: single and fractionated doses.
Joiner MC; Maughan RL; Fowler JF; Denekamp J
Radiat Res; 1983 Jul; 95(1):130-41. PubMed ID: 6878624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]